Sean P. Bohen
Net Worth

Last updated:

What is Sean P. Bohen net worth?

The estimated net worth of Dr. Sean P. Bohen is at least $6,641,924 as of 11 Dec 2024. He owns shares worth $1,331,558 as insider, has earned $2,094,916 from insider trading and has received compensation worth at least $3,215,450 in Olema Pharmaceuticals, Inc..

What is the salary of Sean P. Bohen?

Dr. Sean P. Bohen salary is $643,090 per year as Pres, Chief Executive Officer & Director in Olema Pharmaceuticals, Inc..

How old is Sean P. Bohen?

Dr. Sean P. Bohen is 58 years old, born in 1967.

What stocks does Sean P. Bohen currently own?

As insider, Dr. Sean P. Bohen owns shares in one company:

Company Title Shares Price per share Total value
Olema Pharmaceuticals, Inc. (OLMA) Pres, Chief Executive Officer & Director 241,662 $5.51 $1,331,558

What does Olema Pharmaceuticals, Inc. do?

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

OLMA logo
OLMA
Olema Pharmaceuticals, Inc.
$5.51

Sean P. Bohen insider trading

Olema Pharmaceuticals, Inc.

Dr. Sean P. Bohen has made 12 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 55,907 units of OLMA stock worth $484,155 on 11 Dec 2024.

The largest trade he's ever made was exercising 55,907 units of OLMA stock on 11 Dec 2024. As of 11 Dec 2024 he still owns at least 241,662 units of OLMA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 55,907 $8.66 $484,155
Sale
Common Stock 1,267 $9.39 $11,897
Sale
Common Stock 52,328 $9.37 $490,313
Sale
Common Stock 27,932 $13.9 $388,255
Sale
Common Stock 26,691 $14.84 $396,094
Sale
Common Stock 2,602 $15.29 $39,785
Purchase
Common Stock 20,000 N/A N/A
Sale
Common Stock 5,000 $30.8 $153,975
Option
Common Stock 5,000 $4.82 $24,120
Option
Stock Option (Right to Buy) 5,000 $4.82 $24,120
Option
Stock Option (Right to Buy) 1,085 $4.82 $5,234
Sale
Common Stock 1,085 $30.07 $32,626
Option
Common Stock 1,085 $4.82 $5,234
Sale
Common Stock 2,631 $30 $78,930
Sale
Common Stock 2,631 $4.82 $12,692
Option
Stock Option (Right to Buy) 2,631 $30 $78,930
Option
Common Stock 2,631 $30 $78,930
Option
Common Stock 2,631 $30 $78,930
Option
Common Stock 413 $4.82 $1,992
Option
Stock Option (Right to Buy) 413 $4.82 $1,992
Sale
Common Stock 413 $4.82 $1,992
Option
Stock Option (Right to Buy) 871 $4.82 $4,202
Sale
Common Stock 871 $4.82 $4,202
Option
Common Stock 871 $4.82 $4,202
Option
Stock Option (Right to Buy) 51,649 $4.82 $249,155

Olema Pharmaceuticals key executives

Olema Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: